7-11-19 11:43 AM EDT | Email Article

By Dave Sebastian


Eli Lilly and Co. (LLY) Senior Vice President and General Counsel Mike Harrington is retiring at the end of the year, with a search for his successor underway, the company said Thursday.

Mr. Harrington joined the pharmaceutical company in 1991, taking on roles as managing director of the New Zealand affiliate, associate general counsel for operations in the Asia Pacific region and deputy general counsel of global pharmaceutical operations before being promoted to his current role in 2012.

Mr. Harrington previously worked as a litigator at Baker & Daniels LLP, the predecessor to the law firm Faegre Baker Daniels LLP, according to the Lilly website.

Also leaving the company is Christi Shaw, senior vice president of Lilly and president of its Bio-Medicines business. Ms. Shaw will step down at the end of August, with Patrik Jonsson, the president and general manager of Lilly Japan, succeeding her pending his work authorization in the United States, the company said.

Lilly didn't identify the reason for Ms. Shaw's departure.

Mr. Jonsson joined Lilly in 1990 as a sales representative and has since held marketing and general-manager roles in Europe and Japan, the company said.

Ms. Shaw worked sales and marketing roles at Lilly from 1989 to 2002, according to the company website. Prior to rejoining Lilly in 2017, Ms. Shaw held roles at Novartis AG (NOVN) and Johnson & Johnson (JNJ).


Write to Dave Sebastian at dave.sebastian@wsj.com


(END) Dow Jones Newswires

July 11, 2019 11:43 ET (15:43 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Add a Comment

Try Premium Membership today. Your first 14 days are free of charge. Start my Premium Membership Trial.
Sponsored Links
Buy a Link Now
Sponsor Center
Content Partners